Westfield, NJ, United States of America

Gerard R Kieczykowski


Average Co-Inventor Count = 2.0

ph-index = 6

Forward Citations = 203(Granted Patents)


Company Filing History:


Years Active: 1989-1997

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Gerard R Kieczykowski

Introduction

Gerard R Kieczykowski is a notable inventor based in Westfield, NJ (US), recognized for his contributions to the field of pharmaceuticals. With a total of 9 patents to his name, he has made significant strides in developing compounds that address various cardiovascular disorders.

Latest Patents

Among his latest patents is the development of phenoxyphenylacetic acid derivatives. These compounds exhibit endothelin antagonist activity, making them useful in treating cardiovascular disorders such as hypertension, postischemic renal failure, vasospasm, cerebral and cardiac ischemia, myocardial infarction, endotoxic shock, benign prostatic hyperplasia, and inflammatory diseases including Raynaud's disease and asthma. Another notable patent involves a process for producing n-amino-1-hydroxy-alkyl-idene-1,1-bisphosphonic acid, which further showcases his innovative approach to addressing complex medical issues.

Career Highlights

Gerard R Kieczykowski is currently associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to focus on research and development in the pharmaceutical sector, contributing to advancements that have the potential to improve patient outcomes.

Collaborations

Throughout his career, Kieczykowski has collaborated with esteemed colleagues, including Richard Robert Dauer and Lisa DiMichele. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Gerard R Kieczykowski's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of cardiovascular disorders, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…